PRISCILLA MASSEY: Open Payments
NPI 1093127318 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 48 payments from 29 companies in 2025. Trend: 2023 $900 · 2024 $1,381 · 2025 $1,068
Food & beverage: $969Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $216 |
| ABBVIE INC. | 4 | $87 |
| Janssen Biotech, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $45 |
| PFIZER INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
Products named: Xtandi, ENHERTU, Nubeqa, IMBRUVICA, KEYTRUDA, Venclexta, Padcev, DANZITEN.
Industry payments across SC — which companies pay providers there.
